Management of severe acute pancreatitis: standards and future perspectives

Xin Shi,Ketan R Vagholkar,Helmut Friess,Waldemar Uhl,Markus W Buechler
2001-01-01
Bombay Hospital Journal
Abstract:Severe acute pancreatitis is an inflammatory disease that often takes a complicated and life-threatening course. There is still much controversial debate over treatment of severe acute pancreatitis. Conservative management comprises early diagnosis, prompt and aggressive fluid replenishment, adequate nutritional support, management of pain, and optimal antibiotic therapy. Administration of such extensive conservative treatment is best undertaken in an intensive care unit (ICU), where the response of the patient to the treatment can be closely monitored and judged. Surgical intervention is warranted when there is supervening infection of the necrotic pancreas. Among all the surgical approaches, necrosectomy and continuous local lavage allow debridement of devitalized and infected tissue with preservation of vital pancreatic tissue, and yield good results if performed at the right time. Clinical and experimental studies aim to target the maintenance of the integrity of the intestinal barrier and function, to preserve pancreatic microcirculation, and to balanced and modulate the inflammatory response. However, whether these new approaches will be of major clinical benefit has to be evaluated in randomized clinical trials in the future.Severe acute pancreatitis (SAP) has a complicated and ill-defined pathophysiology. It is associated with a high complication rate and unpredictable outcome. The choice of therapy depends mainly on the judgement of the attending clinician, and presently no specific drug to treat the disease is available. Due to variability of the pathophysiological events in SAP, it is associated with a mortality rate of 10-45%.[1],[2 …
What problem does this paper attempt to address?